Filing Details
- Accession Number:
- 0000899243-20-017612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-24 21:27:37
- Reporting Period:
- 2020-06-23
- Accepted Time:
- 2020-06-24 21:27:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1538927 | Forma Therapeutics Holdings Inc. | FMTX | Biological Products, (No Disgnostic Substances) (2836) | MA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021041 | Peter Wirth | C/O Forma Therapeutics Holdings, Inc. 500 Arsenal Street, Suite 100 Watertown MA 02472 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-23 | 63,299 | $0.00 | 127,665 | No | 4 | P | Direct | |
| Enterprise 1 Junior Stock | Disposition | 2020-06-23 | 25,756 | $0.00 | 0 | No | 4 | S | Direct | |
| Enterprise 2 Junior Stock | Disposition | 2020-06-23 | 18,585 | $0.00 | 0 | No | 4 | S | Direct | |
| Enterprise 3 Junior Stock | Disposition | 2020-06-23 | 9,847 | $0.00 | 0 | No | 4 | S | Direct | |
| Enterprise 4 Junior Stock | Disposition | 2020-06-23 | 10,240 | $0.00 | 0 | No | 4 | S | Direct | |
| Enterprise 5 Junior Stock | Disposition | 2020-06-23 | 14,026 | $0.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Effective immediately upon the closing of the Registrant's initial public offering on June 23, 2020, the reporting person converted (i) 25,756 shares of Enterprise 1 Junior Stock at a conversion rate of 0.9006 shares of common stock per one share of Enterprise 1 Junior Stock, (ii) 18,585 shares of Enterprise 2 Junior Stock at a conversion rate of 0.8179 shares of common stock per one share of Enterprise 2 Junior Stock, (iii) 9,847 shares of Enterprise 3 Junior Stock at a conversion rate of 0.7822 shares of common stock per one share of Enterprise 3 Junior Stock, (iv) 10,240 shares of Enterprise 4 Junior Stock at a conversion rate of 0.7585 shares of common stock per one share of Enterprise 4 Junior Stock, and (v) 14,026 shares of Enterprise 5 Junior Stock at a conversion rate of 0.6727 shares of common stock per one share of Enterprise 5 Junior Stock, resulting in his acquisition of 63,299 shares of common stock.
Billionaire Hedge Funds
